About Acerus Pharma
Acerus Pharma is a company based in Mississauga (Canada) founded in 2008. It operates as a B2B. Acerus Pharma has raised $38.07 million across 14 funding rounds from investors including MidCap Financial, SWK Holdings and Quantius. Acerus Pharma has completed 2 acquisitions, including Serenity and Serenity Pharmaceuticals. Acerus Pharma operates in a competitive market with competitors including Agile Therapeutics, Auxilium Pharmaceuticals, Xanodyne Pharmaceuticals, Microchips Biotech and Marius Pharmaceuticals, among others.
- Headquarter Mississauga, Canada
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$38.07 M (USD)
in 14 rounds
-
Latest Funding Round
$18 M (USD), Post-IPO
Feb 12, 2020
-
Investors
MidCap Financial
& 3 more
-
Employee Count
Not available
-
Investments & Acquisitions
Serenity
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Acerus Pharma
Unlock access to complete
Leadership Team
2 people
Vice Team
1 people
Chairman Team
1 people
Pharmaceutical Team
1 people
Unlock access to complete
Funding Insights of Acerus Pharma
Acerus Pharma has successfully raised a total of $38.07M across 14 strategic funding rounds. The most recent funding activity was a Post-IPO round of $18 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Acerus Pharma
Acerus Pharma has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include MidCap Financial, SWK Holdings and Quantius.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment services are offered by First Generation Capital.
|
Locked | Locked | Locked | |
|
Private debt funds are managed across multiple sectors.
|
Locked | Locked | Locked | |
|
Investments and advisory services are provided by the holding company.
|
Locked | Locked | Locked |
Investor details for Acerus Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acerus Pharma
Acerus Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Serenity and Serenity Pharmaceuticals.
Investment portfolio details for Acerus Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for voiding disorders are developed by Serenity.
|
Locked | Locked | 2006 | Locked | |
|
Novel therapeutics using unique delivery mechanisms combined with low threshold efficacious formulations
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for Acerus Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Acerus Pharma
Detailed financials for Acerus Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acerus Pharma Comparisons
Peer comparison for Acerus Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Acerus Pharma
Acerus Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Agile Therapeutics, Auxilium Pharmaceuticals, Xanodyne Pharmaceuticals, Microchips Biotech and Marius Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for women's healthcare are developed and offered.
|
|
| Locked | Locked | Locked |
Developer of therapeutics and drug-device combinations for urology and sexual health
|
|
| Locked | Locked | Locked |
Developer of drugs for women's health and pain management
|
|
| Locked | Locked | Locked |
Microchip implants for wireless drug delivery are developed.
|
|
| Locked | Locked | Locked |
A proprietary oral testosterone replacement therapy platform is developed.
|
|
| Locked | Locked | Locked |
Pharmaceuticals for PMDD, migraine, and Tourette syndrome are developed.
|
Detailed competitors of Acerus Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acerus Pharma
Complete news archive for Acerus Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acerus Pharma
Acerus Pharma was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Acerus Pharma is headquartered in Mississauga, Canada. It is registered at Mississauga, Ontario, Canada.
Acerus Pharma is a funded company, having raised a total of $38.07M across 14 funding rounds to date.
Acerus Pharma, based in Mississauga, focuses on providing healthcare solutions, producing pharmaceutical products, drug development, and urology and hormone therapy. Develops pharmaceuticals for urology, hormone replacement therapy, and female sexual dysfunction treatments. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
Acerus Pharma's top competitors include Agile Therapeutics, Lipella and Auxilium Pharmaceuticals.
Acerus Pharma has made 2 acquisitions, including Serenity, and Serenity Pharmaceuticals.
Acerus Pharma has 4 investors. Key investors include MidCap Financial, SWK Holdings, Quantius, and First Generation Capital.